AOD-9604 accelerates fat loss. The scientific gap There are no high-quality randomized trials demonstrating that semaglutide + AOD-9604 produces better outcomes than semaglutide alone, or that it improves lean mass retention, resting metabolic rate, or long-term weight maintenance
Boosts mood, mental clarity, and overall well-being
Adverse events: There were no unexpected safety findings, however, gastrointestinal (GI) side effects were a main cause of treatment discontinuation, which occurred in 16.6% of patients in the semaglutide group vs
Reported findings from experimental models include gastrointestinal effects, altered feeding behavior, and dose-dependent metabolic responses
Dehydration, which can occur with semaglutide, may also mask fat loss on the scale by creating water retention